| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.1 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.2 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.057 | 0.2 |